We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 494

Industry objects to FDA's position on soy protein and heart health
  • DLA Piper
  • USA, Canada
  • April 17 2018

In a statement filed with the FDA on March 19, the Center for Responsible Nutrition, which represents the US dietary supplement industry, took issue

Apotex granted damages for delayed FDA approval of two products
  • Smart & Biggar/Fetherstonhaugh
  • USA, Canada
  • February 28 2018

On December 22 2017 the Ontario Superior Court of Justice held that Apotex was entitled to C$11,303,131.80, plus pre-judgment interest, for losses

Apotex granted damages from contract research organization for delayed FDA approval of two products
  • Smart & Biggar/Fetherstonhaugh
  • USA, Canada
  • January 31 2018

On December 22, 2017, Patillo J. of the Ontario Super Court of Justice held that Apotex was entitled to $11,303,131.80, plus pre-judgment interest

Food and Beverage News and Trends
  • DLA Piper
  • USA, Canada
  • January 23 2018

The CDC has issued a warning about a brand of frozen shredded coconut linked to an outbreak of Salmonella that has sickened people in both the US and

Regulators Setting Crosshairs on Unproven Homeopathic Products
  • Bereskin & Parr LLP
  • USA, Canada
  • December 19 2017

Homeopathic products are a growing industry. As more products hit the market, and their popularity increases, regulators in the United States and

Bolar Exemptions in North America
  • Sterne Kessler Goldstein & Fox PLLC
  • USA, Mexico, Canada
  • December 18 2017

Because approval by the U.S. Food and Drug Administration (FDA) is a long, sometimes arduous process, U.S. law provides a research or experimental use

Kymriah, a revolutionary drug to induce treatment remission in recalcitrant cancers
  • Lakshmikumaran & Sridharan
  • USA, Canada
  • October 30 2017

In an unprecedented historic action, the US Food and Drug Administration (FDA) and Oncologic Drugs Advisory Committee (ODAC) unanimously approved

Internet des objets : réduire les risques liés à la sécurité et à la protection de la vie privée dans un monde interrelié
  • Blake Cassels & Graydon LLP
  • USA, Canada
  • October 27 2017

Votre imprimante. Le refroidisseur d’eau. Le thermostat. Qu’est-ce que ces appareils ont en commun? Ils peuvent tous être connectés à l’Internet des

Recall Highlights Medical Device Cybersecurity Issues
  • Knobbe Martens
  • USA, Canada
  • September 13 2017

On August 29, the FDA announced a recall of 465,000 implantable pacemakers, citing concerns that hackers may be able to take control of the

Intellectual Property Weekly Abstracts Bulletin Week of August 28, 2017
  • Borden Ladner Gervais LLP
  • USA, Canada
  • August 28 2017

In this infringement action, the Court held that the Plaintiffs’ trademarks registrations are valid and infringed by the corporate Defendant. The